comparemela.com

Latest Breaking News On - Olajide popoola - Page 1 : comparemela.com

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Molnupiravir did not reduce the frequency of COVID-19-associated hospitalisations or death among high-risk vaccinated adults in the community.

City ofUnited kingdomNorthern irelandYusuf soniJulianne brownMike butlerOlajide popoolaGreg irvingDivya shahAfsana safaJames kennardSarit ghoshSatash sehdevOmair razzaqUmar khanScot richardson

vimarsana © 2020. All Rights Reserved.